Inhibition of host kinase activity altered by the LMP2A signalosome - A therapeutic target for Epstein-Barr virus latency and associated disease

Lori Cooper, Richard Longnecker*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Inhibition of host kinase activity altered by the LMP2A signalosome - A therapeutic target for Epstein-Barr virus latency and associated disease'. Together they form a unique fingerprint.

INIS

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry